DEVELOPMENT OF DISSOLVING POLYMERIC MICRONEEDLES AS AN APPLICATOR FOR OCULAR DRUG DELIVERY SYSTEM
Main Article Content
Abstract
Dissolving polymeric microneedles are micron scale technology and very attractive for minimally invasive intraocular tissue. The application and development of dissolving polymeric microneedles by using biodegradable polymer has been explored as a novel physical method for ocular drug delivery. The purpose of this study was to investigate the appropriate polymer for fabrication of the dissolving polymeric microneedles as an applicator for ocular drug delivery system. The microneedles were fabricated by micro-molding technique using hydroxypropyl methylcellulose (HPMC) mixed with polyvinylpyrrolidone K30 (PVP K30) in various concentrations: C1 (10%HPMC), C2 (10%HPMC:10%PVP K30), C3 (10%HPMC:15%PVP K30) and C4 (10%HPMC:20%PVP K30). The physical appearance under microscope, mechanical strength by texture analyzer, and dissolution study by measuring the microneedle height inserting in the ocular tissues at predetermined time were evaluated. All formulations could produce microneedle arrays (11 rowsx11 columns) with 10 mm2 of microneedle patch area and conical shape needle. The height and base diameter of microneedle were 530 ± 25 μm and 300 ± 3 μm, respectively. The change of percent needle height of C1, C2, C3 and C4 in the mechanical strength (bending force and fracture force; 1.8, 2.8, 3.8, 5.8 and 8.8 N) showed that formulations were added 15% and 20%PVP K30 changing percent needle height significantly less than C1 and C2. However, some needle of C4 could be fractured since 5.8 N. The dissolution result showed that dissolving polymeric microneedles were completely dissolved within 180 seconds. In conclusion, the fabrication of dissolving polymeric microneedles by mixing HPMC and PVP K30 polymer in the appropriate ratio provided the suitable microneedle properties for ocular drug delivery.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Journal of TCI is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) licence, unless otherwise stated. Please read our Policies page for more information.
References
Cheung K, Das DB. 2016. Microneedles for drug delivery: trends and progress. Drug Delivery. 23(7): 2338-2354.
Järvinen K, Järvinen T, Urtti A. 1995. Ocular absorption following topical delivery. Advanced Drug Delivery Reviews. 16(1): 3-19.
Kim JY, Han MR, Kim YH, Shin SW, Nam SY, Park JH. 2016. Tip-loaded dissolving microneedles for transdermal delivery of donepezil hydrochloride for treatment of Alzheimer's disease. European Journal of Pharmaceutics and Biopharmaceutics. 105: 148-155.
Lee JW, Park JH, Prausnitz MR. 2008. Dissolving microneedles for transdermal drug delivery. Biomaterials. 29(13): 2113-2124.
Mansour HM, Sohn M, Al-Ghananeem A, Deluca PP. 2010. Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects. International Journal of Molecular Sciences. 11(9): 3298-3322.
Maurice D. 2001. Review: practical issues in intravitreal drug delivery. Journal of Ocular Pharmacology and Therapeutics. 17(4): 393-401.
Nicoli S, Ferrari G, Quarta M, Macaluso C, Govoni P, Dallatana D, Santi P. 2009. Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability. Molecular Vision. 15: 259-266.
Pascolini D & Mariotti SP. 2012. Global estimates of visual impairment: 2010. British Journal of Ophthalmology. 96(5): 614-618.
Pethig R, Kell DB. 1987. The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology. Physics in Medicine and Biology. 32(8): 933-970.
Sanchez I, Martin R, Ussa F, Fernandez-Bueno I. 2011. The parameters of the porcine eyeball. Graefe's Archive for Clinical and Experimental Ophthalmology. 249(4): 475-482.
Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Prausnitz MR. 2010. Dissolving polymer microneedle patches for influenza vaccination. Nature Medicine. 16(8): 915-920.
Thakur RR, Tekko IA, Al-Shammari F, Ali AA, McCarthy H, Donnelly RF. 2016. Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery. Drug Delivery and Translational Research. 6(6): 800-815.
Thakur Singh RR, Tekko I, McAvoy K, McMillan H, Jones D, Donnelly RF. 2017. Minimally invasive microneedles for ocular drug delivery. Expert Opinion on Drug Delivery. 14(4): 525-537.
Yellepeddi VK, Sheshala R, McMillan H, Gujral C, Jones D, Raghu Raj Singh T. 2015. Punctal plug: a medical device to treat dry eye syndrome and for sustained drug delivery to the eye. Drug Discovery Today. 20(7): 884-889.